banner add

Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval

The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.

from NYT > Health https://ift.tt/gUcbDSE
via IFTTT

No comments

A New Drug Lifts the Fog of Sleepiness for Those With Narcolepsy

The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. from NYT > Health https://ift.tt...

Theme images by PLAINVIEW. Powered by Blogger.